Latest Multiple Myeloma Research Foundation Stories
Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with other drugs, such as bortezomib and lenalidomide.
Mitchell Vazquez, owner of the GCI Financial, makes noble use of his financial success by donating substantial gifts to Multiple Myeloma Research Foundation.
Mitch Vazquez, an enthusiastic philanthropic donor offers aid to the Advance Cancer Research philanthropy.
- A political dynamiter.